Plus Therapeutics (NASDAQ:CNSY – Get Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks reports. Separately, Weiss Ratings initiated coverage on shares of Plus Therapeutics in a report on Tuesday, August 4th. They […]

Nutanix (NASDAQ:NTNX – Get Free Report) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports. Several other equities analysts have also recently weighed in on the stock. JPMorgan Chase & Co. raised their price target on shares […]

Concentrix (NASDAQ:CNXC – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday, Zacks reports. A number of other equities analysts also recently weighed in on CNXC. Canaccord Genuity Group dropped their target price on shares of Concentrix from $55.00 […]